APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Liver Cirrhosis Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Liver Cirrhosis Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174008430320 December 2025197 pages

Choose your research edition.

Industry ResearchLiver Cirrhosis Therapeutics Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Liver Cirrhosis Therapeutics Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Liver Cirrhosis Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liver Cirrhosis Therapeutics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Liver Cirrhosis Therapeutics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Liver Cirrhosis Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Liver Cirrhosis Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liver Cirrhosis Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liver Cirrhosis Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Liver Cirrhosis Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Liver Cirrhosis Therapeutics include Bristol-Myers Squibb, Conatus Pharmaceuticals, Gilead Sciences, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, NGM Biopharmaceuticals, Norgine and Pharmicell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Liver Cirrhosis Therapeutics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liver Cirrhosis Therapeutics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liver Cirrhosis Therapeutics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Liver Cirrhosis Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Liver Cirrhosis Therapeutics Segment by Company

Bristol-Myers Squibb

Conatus Pharmaceuticals

Gilead Sciences

Gwo Xi Stem Cell Applied Technology

Instituto Grifols

Intercept Pharmaceuticals

NGM Biopharmaceuticals

Norgine

Pharmicell

Salix Pharmaceuticals

Stempeutics Research

GlaxoSmithKline

Roche

Merck

Johnson & Johnson

Liver Cirrhosis Therapeutics Segment by Type

Oral Liver Cirrhosis Therapeutics Drugs

Injection Liver Cirrhosis Therapeutics Drugs

Liver Cirrhosis Therapeutics Segment by Application

Hospitals

Clinics

Other

Liver Cirrhosis Therapeutics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Cirrhosis Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liver Cirrhosis Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Cirrhosis Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Liver Cirrhosis Therapeutics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liver Cirrhosis Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Liver Cirrhosis Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Liver Cirrhosis Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Liver Cirrhosis Therapeutics Industry Trends Table 2. Liver Cirrhosis Therapeutics Industry Drivers Table 3. Liver Cirrhosis Therapeutics Industry Opportunities and Challenges Table 4. Liver Cirrhosis Therapeutics Industry Restraints Table 5. Global Liver Cirrhosis Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Liver Cirrhosis Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Liver Cirrhosis Therapeutics Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Liver Cirrhosis Therapeutics Sales Market Share by Manufacturers Table 9. Global Liver Cirrhosis Therapeutics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Liver Cirrhosis Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Liver Cirrhosis Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Liver Cirrhosis Therapeutics Manufacturers, Product Type & Application Table 13. Global Liver Cirrhosis Therapeutics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Liver Cirrhosis Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Liver Cirrhosis Therapeutics Drugs Table 17. Major Manufacturers of Injection Liver Cirrhosis Therapeutics Drugs Table 18. Global Liver Cirrhosis Therapeutics Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 19. Global Liver Cirrhosis Therapeutics Sales by Type (2021-2026) & (W Units) Table 20. Global Liver Cirrhosis Therapeutics Sales by Type (2027-2032) & (W Units) Table 21. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2021-2026) Table 22. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2027-2032) Table 23. Global Liver Cirrhosis Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 24. Global Liver Cirrhosis Therapeutics Revenue by Type (2021-2026) & (W Units) Table 25. Global Liver Cirrhosis Therapeutics Revenue by Type (2027-2032) & (W Units) Table 26. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2021-2026) Table 27. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Other Table 31. Global Liver Cirrhosis Therapeutics Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 32. Global Liver Cirrhosis Therapeutics Sales by Application (2021-2026) & (W Units) Table 33. Global Liver Cirrhosis Therapeutics Sales by Application (2027-2032) & (W Units) Table 34. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2021-2026) Table 35. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2027-2032) Table 36. Global Liver Cirrhosis Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Liver Cirrhosis Therapeutics Revenue by Application (2021-2026) & (W Units) Table 38. Global Liver Cirrhosis Therapeutics Revenue by Application (2027-2032) & (W Units) Table 39. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2021-2026) Table 40. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2027-2032) Table 41. Global Liver Cirrhosis Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 42. Global Liver Cirrhosis Therapeutics Sales by Region (2021-2026) & (W Units) Table 43. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2021-2026) Table 44. Global Liver Cirrhosis Therapeutics Sales Forecasted by Region (2027-2032) & (W Units) Table 45. Global Liver Cirrhosis Therapeutics Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Liver Cirrhosis Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 47. North America Liver Cirrhosis Therapeutics Sales by Country (2021-2026) & (W Units) Table 48. North America Liver Cirrhosis Therapeutics Sales by Country (2027-2032) & (W Units) Table 49. Europe Liver Cirrhosis Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 50. Europe Liver Cirrhosis Therapeutics Sales by Country (2021-2026) & (W Units) Table 51. Europe Liver Cirrhosis Therapeutics Sales by Country (2027-2032) & (W Units) Table 52. Asia Pacific Liver Cirrhosis Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 53. Asia Pacific Liver Cirrhosis Therapeutics Sales by Country (2021-2026) & (W Units) Table 54. Asia Pacific Liver Cirrhosis Therapeutics Sales by Country (2027-2032) & (W Units) Table 55. South America, Middle East and Africa Liver Cirrhosis Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. South America, Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2021-2026) & (W Units) Table 57. South America, Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2027-2032) & (W Units) Table 58. Global Liver Cirrhosis Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Liver Cirrhosis Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Liver Cirrhosis Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2021-2026) Table 62. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2027-2032) Table 63. Bristol-Myers Squibb Company Information Table 64. Bristol-Myers Squibb Business Overview Table 65. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product Portfolio Table 67. Bristol-Myers Squibb Recent Development Table 68. Conatus Pharmaceuticals Company Information Table 69. Conatus Pharmaceuticals Business Overview Table 70. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio Table 72. Conatus Pharmaceuticals Recent Development Table 73. Gilead Sciences Company Information Table 74. Gilead Sciences Business Overview Table 75. Gilead Sciences Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Gilead Sciences Liver Cirrhosis Therapeutics Product Portfolio Table 77. Gilead Sciences Recent Development Table 78. Gwo Xi Stem Cell Applied Technology Company Information Table 79. Gwo Xi Stem Cell Applied Technology Business Overview Table 80. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product Portfolio Table 82. Gwo Xi Stem Cell Applied Technology Recent Development Table 83. Instituto Grifols Company Information Table 84. Instituto Grifols Business Overview Table 85. Instituto Grifols Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Instituto Grifols Liver Cirrhosis Therapeutics Product Portfolio Table 87. Instituto Grifols Recent Development Table 88. Intercept Pharmaceuticals Company Information Table 89. Intercept Pharmaceuticals Business Overview Table 90. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio Table 92. Intercept Pharmaceuticals Recent Development Table 93. NGM Biopharmaceuticals Company Information Table 94. NGM Biopharmaceuticals Business Overview Table 95. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio Table 97. NGM Biopharmaceuticals Recent Development Table 98. Norgine Company Information Table 99. Norgine Business Overview Table 100. Norgine Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Norgine Liver Cirrhosis Therapeutics Product Portfolio Table 102. Norgine Recent Development Table 103. Pharmicell Company Information Table 104. Pharmicell Business Overview Table 105. Pharmicell Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pharmicell Liver Cirrhosis Therapeutics Product Portfolio Table 107. Pharmicell Recent Development Table 108. Salix Pharmaceuticals Company Information Table 109. Salix Pharmaceuticals Business Overview Table 110. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio Table 112. Salix Pharmaceuticals Recent Development Table 113. Stempeutics Research Company Information Table 114. Stempeutics Research Business Overview Table 115. Stempeutics Research Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Stempeutics Research Liver Cirrhosis Therapeutics Product Portfolio Table 117. Stempeutics Research Recent Development Table 118. GlaxoSmithKline Company Information Table 119. GlaxoSmithKline Business Overview Table 120. GlaxoSmithKline Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. GlaxoSmithKline Liver Cirrhosis Therapeutics Product Portfolio Table 122. GlaxoSmithKline Recent Development Table 123. Roche Company Information Table 124. Roche Business Overview Table 125. Roche Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Roche Liver Cirrhosis Therapeutics Product Portfolio Table 127. Roche Recent Development Table 128. Merck Company Information Table 129. Merck Business Overview Table 130. Merck Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Merck Liver Cirrhosis Therapeutics Product Portfolio Table 132. Merck Recent Development Table 133. Johnson & Johnson Company Information Table 134. Johnson & Johnson Business Overview Table 135. Johnson & Johnson Liver Cirrhosis Therapeutics Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Johnson & Johnson Liver Cirrhosis Therapeutics Product Portfolio Table 137. Johnson & Johnson Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Liver Cirrhosis Therapeutics Distributors List Table 141. Liver Cirrhosis Therapeutics Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Liver Cirrhosis Therapeutics Product Image Figure 2. Global Liver Cirrhosis Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liver Cirrhosis Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Liver Cirrhosis Therapeutics Sales (2021-2032) & (W Units) Figure 5. Global Liver Cirrhosis Therapeutics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Liver Cirrhosis Therapeutics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Liver Cirrhosis Therapeutics Drugs Image Figure 9. Injection Liver Cirrhosis Therapeutics Drugs Image Figure 10. Global Liver Cirrhosis Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 11. Global Liver Cirrhosis Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2021-2032) Figure 13. Global Liver Cirrhosis Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Liver Cirrhosis Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Other Image Figure 19. Global Liver Cirrhosis Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 20. Global Liver Cirrhosis Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2021-2032) Figure 22. Global Liver Cirrhosis Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Liver Cirrhosis Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2021-2032) Figure 25. North America Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 26. North America Liver Cirrhosis Therapeutics Sales Market Share by Country (2021-2032) Figure 27. U.S. Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 28. Canada Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Mexico Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Europe Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Liver Cirrhosis Therapeutics Sales Market Share by Country (2021-2032) Figure 32. Germany Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 33. France Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 34. U.K. Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Italy Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Netherlands Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Asia Pacific Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Liver Cirrhosis Therapeutics Sales Market Share by Country (2021-2032) Figure 39. China Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Japan Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 41. South Korea Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Southeast Asia Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 43. India Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 44. Australia Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 45. South America, Middle East and Africa Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Liver Cirrhosis Therapeutics Sales Market Share by Country (2021-2032) Figure 47. Brazil Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 48. South Africa Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Saudi Arabia Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Turkey Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Argentina Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 52. UAE Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 53. Egypt Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Chile Liver Cirrhosis Therapeutics Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Global Liver Cirrhosis Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Figure 58. North America Liver Cirrhosis Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Figure 60. Europe Liver Cirrhosis Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Liver Cirrhosis Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Liver Cirrhosis Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Liver Cirrhosis Therapeutics Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Liver Cirrhosis Therapeutics Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Liver Cirrhosis Therapeutics Drugs
  • Injection Liver Cirrhosis Therapeutics Drugs
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Bristol-Myers Squibb
  • Conatus Pharmaceuticals
  • Gilead Sciences
  • Gwo Xi Stem Cell Applied Technology
  • Instituto Grifols
  • Intercept Pharmaceuticals
  • NGM Biopharmaceuticals
  • Norgine
  • Pharmicell
  • Salix Pharmaceuticals
  • Stempeutics Research
  • GlaxoSmithKline
  • Roche
  • Merck
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Liver Cirrhosis Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Liver Cirrhosis Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Liver Cirrhosis Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Liver Cirrhosis Therapeutics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Liver Cirrhosis Therapeutics Market Dynamics
  1. 2.1 Liver Cirrhosis Therapeutics Industry Trends
  2. 2.2 Liver Cirrhosis Therapeutics Industry Drivers
  3. 2.3 Liver Cirrhosis Therapeutics Industry Opportunities and Challenges
  4. 2.4 Liver Cirrhosis Therapeutics Industry Restraints
3 Liver Cirrhosis Therapeutics Market by Manufacturers
  1. 3.1 Global Liver Cirrhosis Therapeutics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Liver Cirrhosis Therapeutics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Liver Cirrhosis Therapeutics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Liver Cirrhosis Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liver Cirrhosis Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Liver Cirrhosis Therapeutics Manufacturers, Product Type & Application
  7. 3.7 Global Liver Cirrhosis Therapeutics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liver Cirrhosis Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liver Cirrhosis Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liver Cirrhosis Therapeutics Tier 1, Tier 2, and Tier 3
4 Liver Cirrhosis Therapeutics Market by Type
  1. 4.1 Liver Cirrhosis Therapeutics Type Introduction
  2. 4.1.1 Oral Liver Cirrhosis Therapeutics Drugs
  3. 4.1.2 Injection Liver Cirrhosis Therapeutics Drugs
  4. 4.2 Global Liver Cirrhosis Therapeutics Sales by Type
  5. 4.2.1 Global Liver Cirrhosis Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Liver Cirrhosis Therapeutics Sales by Type (2021-2032)
  7. 4.2.3 Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2021-2032)
  8. 4.3 Global Liver Cirrhosis Therapeutics Revenue by Type
  9. 4.3.1 Global Liver Cirrhosis Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Liver Cirrhosis Therapeutics Revenue by Type (2021-2032)
  11. 4.3.3 Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2021-2032)
5 Liver Cirrhosis Therapeutics Market by Application
  1. 5.1 Liver Cirrhosis Therapeutics Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Liver Cirrhosis Therapeutics Sales by Application
  6. 5.2.1 Global Liver Cirrhosis Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liver Cirrhosis Therapeutics Sales by Application (2021-2032)
  8. 5.2.3 Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2021-2032)
  9. 5.3 Global Liver Cirrhosis Therapeutics Revenue by Application
  10. 5.3.1 Global Liver Cirrhosis Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Liver Cirrhosis Therapeutics Revenue by Application (2021-2032)
  12. 5.3.3 Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2021-2032)
6 Global Liver Cirrhosis Therapeutics Sales by Region
  1. 6.1 Global Liver Cirrhosis Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liver Cirrhosis Therapeutics Sales by Region (2021-2032)
  3. 6.2.1 Global Liver Cirrhosis Therapeutics Sales by Region (2021-2026)
  4. 6.2.2 Global Liver Cirrhosis Therapeutics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Liver Cirrhosis Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Liver Cirrhosis Therapeutics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Liver Cirrhosis Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Liver Cirrhosis Therapeutics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Liver Cirrhosis Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Liver Cirrhosis Therapeutics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Liver Cirrhosis Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Liver Cirrhosis Therapeutics Revenue by Region
  1. 7.1 Global Liver Cirrhosis Therapeutics Revenue by Region
  2. 7.1.1 Global Liver Cirrhosis Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Liver Cirrhosis Therapeutics Revenue by Region (2021-2026)
  4. 7.1.3 Global Liver Cirrhosis Therapeutics Revenue by Region (2027-2032)
  5. 7.1.4 Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Liver Cirrhosis Therapeutics Revenue (2021-2032)
  8. 7.2.2 North America Liver Cirrhosis Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Liver Cirrhosis Therapeutics Revenue (2021-2032)
  11. 7.3.2 Europe Liver Cirrhosis Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Liver Cirrhosis Therapeutics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Liver Cirrhosis Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Liver Cirrhosis Therapeutics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Liver Cirrhosis Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bristol-Myers Squibb
  2. 8.1.1 Bristol-Myers Squibb Company Information
  3. 8.1.2 Bristol-Myers Squibb Business Overview
  4. 8.1.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product Portfolio
  6. 8.1.5 Bristol-Myers Squibb Recent Developments
  7. 8.2 Conatus Pharmaceuticals
  8. 8.2.1 Conatus Pharmaceuticals Company Information
  9. 8.2.2 Conatus Pharmaceuticals Business Overview
  10. 8.2.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio
  12. 8.2.5 Conatus Pharmaceuticals Recent Developments
  13. 8.3 Gilead Sciences
  14. 8.3.1 Gilead Sciences Company Information
  15. 8.3.2 Gilead Sciences Business Overview
  16. 8.3.3 Gilead Sciences Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gilead Sciences Liver Cirrhosis Therapeutics Product Portfolio
  18. 8.3.5 Gilead Sciences Recent Developments
  19. 8.4 Gwo Xi Stem Cell Applied Technology
  20. 8.4.1 Gwo Xi Stem Cell Applied Technology Company Information
  21. 8.4.2 Gwo Xi Stem Cell Applied Technology Business Overview
  22. 8.4.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product Portfolio
  24. 8.4.5 Gwo Xi Stem Cell Applied Technology Recent Developments
  25. 8.5 Instituto Grifols
  26. 8.5.1 Instituto Grifols Company Information
  27. 8.5.2 Instituto Grifols Business Overview
  28. 8.5.3 Instituto Grifols Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Instituto Grifols Liver Cirrhosis Therapeutics Product Portfolio
  30. 8.5.5 Instituto Grifols Recent Developments
  31. 8.6 Intercept Pharmaceuticals
  32. 8.6.1 Intercept Pharmaceuticals Company Information
  33. 8.6.2 Intercept Pharmaceuticals Business Overview
  34. 8.6.3 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio
  36. 8.6.5 Intercept Pharmaceuticals Recent Developments
  37. 8.7 NGM Biopharmaceuticals
  38. 8.7.1 NGM Biopharmaceuticals Company Information
  39. 8.7.2 NGM Biopharmaceuticals Business Overview
  40. 8.7.3 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio
  42. 8.7.5 NGM Biopharmaceuticals Recent Developments
  43. 8.8 Norgine
  44. 8.8.1 Norgine Company Information
  45. 8.8.2 Norgine Business Overview
  46. 8.8.3 Norgine Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Norgine Liver Cirrhosis Therapeutics Product Portfolio
  48. 8.8.5 Norgine Recent Developments
  49. 8.9 Pharmicell
  50. 8.9.1 Pharmicell Company Information
  51. 8.9.2 Pharmicell Business Overview
  52. 8.9.3 Pharmicell Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pharmicell Liver Cirrhosis Therapeutics Product Portfolio
  54. 8.9.5 Pharmicell Recent Developments
  55. 8.10 Salix Pharmaceuticals
  56. 8.10.1 Salix Pharmaceuticals Company Information
  57. 8.10.2 Salix Pharmaceuticals Business Overview
  58. 8.10.3 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio
  60. 8.10.5 Salix Pharmaceuticals Recent Developments
  61. 8.11 Stempeutics Research
  62. 8.11.1 Stempeutics Research Company Information
  63. 8.11.2 Stempeutics Research Business Overview
  64. 8.11.3 Stempeutics Research Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Stempeutics Research Liver Cirrhosis Therapeutics Product Portfolio
  66. 8.11.5 Stempeutics Research Recent Developments
  67. 8.12 GlaxoSmithKline
  68. 8.12.1 GlaxoSmithKline Company Information
  69. 8.12.2 GlaxoSmithKline Business Overview
  70. 8.12.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Product Portfolio
  72. 8.12.5 GlaxoSmithKline Recent Developments
  73. 8.13 Roche
  74. 8.13.1 Roche Company Information
  75. 8.13.2 Roche Business Overview
  76. 8.13.3 Roche Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Roche Liver Cirrhosis Therapeutics Product Portfolio
  78. 8.13.5 Roche Recent Developments
  79. 8.14 Merck
  80. 8.14.1 Merck Company Information
  81. 8.14.2 Merck Business Overview
  82. 8.14.3 Merck Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Merck Liver Cirrhosis Therapeutics Product Portfolio
  84. 8.14.5 Merck Recent Developments
  85. 8.15 Johnson & Johnson
  86. 8.15.1 Johnson & Johnson Company Information
  87. 8.15.2 Johnson & Johnson Business Overview
  88. 8.15.3 Johnson & Johnson Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Johnson & Johnson Liver Cirrhosis Therapeutics Product Portfolio
  90. 8.15.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Liver Cirrhosis Therapeutics Value Chain Analysis
  2. 9.1.1 Liver Cirrhosis Therapeutics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Liver Cirrhosis Therapeutics Production Mode & Process
  6. 9.2 Liver Cirrhosis Therapeutics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Liver Cirrhosis Therapeutics Distributors
  9. 9.2.3 Liver Cirrhosis Therapeutics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst